SB3213 amends the Federal Food, Drug, and Cosmetic Act to give the Secretary of Health and Human Services explicit authority to destroy any article refused admission at the border when the Secretary determines the article presents a significant public health concern. It also broadens existing language that once referenced only "drug or device" to cover "drug, device, or other article," and adds a new prohibited act making unauthorized movement or introduction into interstate commerce — including export — of an article ordered destroyed unlawful under the FDCA.
The change shortens one pathway for hazardous imports to be removed from commerce, but it shifts burdens onto importers, port operators, carriers, and waste handlers and raises operational, legal, and trade questions. The bill sets tight deadlines for agency regulations and requires consistency with international agreements, leaving key procedural details (for example, how the Secretary will define and announce a "significant public health concern" and how owners can seek relief) to agency rulemaking.
At a Glance
What It Does
Amends 21 U.S.C. 381(a) (section 801(a)) to allow the Secretary to order destruction of any refused import the Secretary determines poses a significant public health concern, and replaces limited "drug or device" language with "drug, device, or other article." It adds new FDCA prohibited act 21 U.S.C. 331(jjj) to bar unauthorized movement or introduction into interstate commerce — including export — of articles ordered destroyed.
Who It Affects
Importers and foreign manufacturers of FDA-regulated goods and other articles refused admission, customs brokers, carriers and port operators that handle refused shipments, state/local waste contractors who may receive destruction responsibility, and FDA and Customs and Border Protection (CBP) for enforcement and coordination.
Why It Matters
The bill materially expands FDA's removal toolbox and makes circumventing destruction an explicit FDCA violation, increasing potential civil and criminal exposure. It also creates operational and compliance responsibilities across the supply chain and raises questions about disposal logistics and alignment with U.S. trade obligations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB3213 narrows the path between refusal at the border and permanent removal from U.S. commerce. Under current FDCA text, certain sentences in section 801(a) contemplate destruction authority in narrow circumstances; this bill amends that provision so the Secretary may order destruction of any article refused admission if the Secretary finds it presents a "significant public health concern." The statutory change is textual: it expands how the FD&C Act talks about covered items by swapping "drug or device" for "drug, device, or other article" in the immediately following sentences, which broadens the kinds of imports that may be treated under the destruction authority.
The bill does more than authorize destruction: it makes unauthorized movement, introduction into interstate commerce, or export of an item the Secretary has decided to destroy a new prohibited act under the FDCA. That addition imports the FDCA's enforcement framework into these situations — civil penalties, injunctions, and, where applicable, criminal enforcement — meaning anyone who moves or attempts to move an ordered-for-destruction item could face FDA enforcement action or prosecution under existing FDCA authorities.SB3213 sets two implementation deadlines.
The statutory amendments take effect 180 days after enactment, giving businesses a six-month runway before the new rule applies. Separately, the bill requires the HHS Secretary, acting through the FDA Commissioner, to finalize any necessary regulatory revisions within 90 days of enactment and to ensure the regulations comport with applicable international agreements.
The bill itself does not define "significant public health concern," prescribe notice procedures to owners of refused goods, or set detailed procedures for destruction, transfer, or cost recovery; those procedural elements are left to the FDA's forthcoming regulations.Practically, this shifts several decision points to the agency and operational actors. FDA will need to coordinate closely with CBP on custody and chain-of-possession after a refusal; importers and carriers will need new compliance controls to avoid the new prohibited act; and ports and waste handlers must prepare for potentially increased volumes of hazardous or regulated material that cannot be re-exported or returned without authorization.
The bill also flags international trade considerations by requiring regulations to be consistent with international agreements, which limits but does not eliminate potential friction with trading partners.
The Five Things You Need to Know
The bill amends 21 U.S.C. 381(a) (section 801(a)) to authorize destruction of any article refused admission if the Secretary determines it presents a "significant public health concern.", It replaces the phrase "drug or device" with "drug, device, or other article" in the three sentences following the seventh sentence of section 801(a), broadening the statutory scope beyond traditional FDA-regulated products.
A new FDCA prohibited act, codified as 21 U.S.C. 331(jjj), makes unauthorized movement or introduction into interstate commerce, including export, of an article that the Secretary has decided to destroy unlawful and subject to FDCA enforcement.
The substantive amendments take effect 180 days after enactment, while the bill requires the FDA Commissioner to finalize implementing regulations within 90 days and to align them with applicable international agreements.
The statute leaves critical terms and procedures undefined — notably "significant public health concern," notice to owners, and destruction logistics — placing those decisions in the forthcoming FDA regulations.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — "Destruction of Hazardous Imports Act"
This is the formal short title. It does not change legal obligations but signals the bill's policy focus on removing hazardous imports from commerce more assertively.
Extends destruction authority to any 'refused' article presenting public-health risk
This clause inserts authority in the seventh sentence of 801(a) authorizing the Secretary to destroy any article refused admission if the Secretary determines it presents a "significant public health concern." It also edits the three subsequent sentences to substitute "drug, device, or other article" for "drug or device," thereby broadening the textual scope of the destruction framework to cover nontraditional or novel imports not previously captured by the narrower language. Practically, that rewording means items that were formerly outside the narrow "drug or device" phrasing can now fall under the same destruction regime.
Creates a new prohibited act for unauthorized movement or export of ordered-for-destruction items
This subsection adds paragraph (jjj) to section 301, declaring it unlawful to move, introduce, or deliver for introduction into interstate commerce — explicitly including export — an article that the Secretary has decided to destroy under the amended seventh sentence of 801(a). By making that conduct a prohibited act, the bill leverages the FDCA's existing enforcement tools (administrative action, civil penalties, injunctions, and potential criminal referral) against anyone who attempts to remove or move such articles after an FDA destruction decision.
Delayed effective date
The amendments apply beginning 180 days after enactment. That delayed effective date gives industry and agencies a six-month transition window to adapt policies, contracts, and operational procedures before the new statutory authority is in force.
Regulatory implementation and international-consistency requirement
The Secretary, acting through the FDA Commissioner, must finalize necessary regulatory revisions not later than 90 days after enactment and must ensure the regulations are consistent with applicable international agreements. This places a short, affirmative duty on the agency to fill in implementation details but also constrains the agency to account for trade obligations when setting procedures for destruction, notification, and coordination with other agencies.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Consumers and public health authorities — faster removal of imports judged to present immediate public-health threats reduces risk of exposure to contaminated, counterfeit, or otherwise hazardous articles.
- FDA and HHS policymakers — gains an explicit statutory tool to direct destruction of a broader set of refused goods, simplifying legal authority in acute-risk scenarios.
- State and local health agencies — potential reduction in downstream incidents (illness outbreaks, environmental contamination) when hazardous goods are removed promptly at the border or port.
- Export control and trade compliance professionals — clearer statutory prohibition on re-export or illicit movement after a destruction order, which helps compliance programs flag high-risk shipments earlier.
Who Bears the Cost
- Importers and foreign manufacturers — face increased risk that refused shipments will be destroyed rather than returned, creating potential product losses and higher compliance and insurance costs.
- Customs brokers, carriers, and port operators — must implement controls to avoid moving articles ordered destroyed and may face enforcement exposure or operational disruption when custody is contested.
- Waste management and disposal contractors — may see increased demand for secure destruction and hazardous-waste handling, including costs and regulatory compliance burdens for disposal chains.
- FDA and CBP — must allocate staff and resources to coordinate determinations, custody, enforcement, and disposal logistics under tight regulatory deadlines.
- U.S. trade negotiators and legal counsel for importers — may need to manage disputes or compliance issues tied to international obligations and potential claims from foreign firms or trading partners.
Key Issues
The Core Tension
The bill balances rapid public-health protection against the property and trade interests of importers, carriers, and foreign manufacturers: empowering the Secretary to destroy hazardous imports reduces public exposure but shifts costs and legal risk onto private parties and raises questions about due process, international obligations, and practical disposal logistics.
The bill leaves central procedural and substantive questions unaddressed and pushes them to regulation. "Significant public health concern" is not defined, so the scope of the Secretary's judgment will depend on forthcoming FDA rulemaking and internal guidance. That creates enforcement uncertainty for importers and carriers during the 180-day transition and thereafter, because whether a given refused article triggers destruction will rest on an agency standard that could vary with public-health priorities and risk tolerance.
Operationally, destruction of potentially hazardous imports raises regulatory and logistical complexities: chain-of-custody after refusal, responsibility and cost for transport to destruction facilities, environmental and hazardous-waste disposal requirements under federal and state law, and safe handling procedures for ports and contractors. The bill requires regulations to be consistent with international agreements, but it does not reconcile possible tensions with WTO or bilateral obligations regarding confiscation, return of goods, or export controls.
Adding unauthorized export to the new prohibited act broadens enforcement reach but also risks criminalizing actions by actors who may lack notice or clarity about FDA orders, especially in cross-border contexts.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.